Astellas Pharma Inc: all 983 studies
Page 4 of 10. Open to participants first (40), then studies with results posted, then the rest; newest registration first within each.
- A Study of Enfortumab Vedotin Alone or With Other Therapies for Treatment of Urothelial CancerTerminatedNCT03288545Phase 1/2
- A Study to Investigate Efficacy, Safety, Pharmacodynamics and Pharmacokinetics of ASP6294 in the Treatment of Female Subjects With Bladder Pain Syndrome/Interstitial CystitisCompletedNCT03282318Phase 2
- Development of Visual Function Evaluation MethodCompletedNCT03281005
- A Multiple-dose Study of ASP8374, an Immune Checkpoint Inhibitor, as a Single Agent and in Combination With Pembrolizumab in Subjects With Advanced Solid TumorsCompletedNCT03260322Phase 1
- A Study to Evaluate the Efficacy and Safety of ASP5094 in Patients With Rheumatoid Arthritis on MethotrexateCompletedNCT03257852Phase 2
- A Study of Intravenous and Oral Isavuconazonium Sulfate in Pediatric PatientsCompletedNCT03241550Phase 1
- Gene Transfer Clinical Study in Crigler-Najjar SyndromeTerminatedNCT03223194Phase 1
- Study to Evaluate the Safety and Tolerability of ASP8062 in Healthy Japanese Male and Female SubjectsCompletedNCT03183739Phase 1
- Non-interventional Study for Prevention and Treatment of Fungal Infections in Paediatric Patients in Asia/Oceania - ERADICATE StudyCompletedNCT03174457
- A Study to Evaluate the Renal Protective Effect (Urine Albumin-to-Creatinine Ratio (UACR)), Efficacy and Safety of Ipragliflozin in Type 2 Diabetes Mellitus Patients With AlbuminuriaTerminatedNCT03118713Phase 4
- A Study to Assess the Safety, Tolerability and Pharmacokinetics of ASP7713 in Healthy Non-Japanese Adult and Elderly Subjects and Healthy Japanese Adult SubjectsCompletedNCT03108755Phase 1
- A Study of ASP8273 in Subjects With Non-small Cell Lung Cancer (NSCLC) Harboring Epidermal Growth Factor Receptor (EGFR) MutationsTerminatedNCT03082300Phase 1
- Clinical Assessment Study in Crigler-Najjar SyndromeCompletedNCT03078881
- A Study of Enfortumab Vedotin in Japanese Subjects With Locally Advanced or Metastatic Urothelial CarcinomaCompletedNCT03070990Phase 1
- Expanded Access Study of Gilteritinib (ASP2215) in Patients With FMS-like Tyrosine Kinase 3 (FLT3) Mutated Relapsed or Refractory Acute Myeloid Leukemia (AML) or FLT3-Mutated AML in Complete Remission (CR) With Minimal Residual Disease (MRD)Approved for marketingNCT03070093
- Registry of Patients Treated With Systemic Mold-Active TriazolesCompletedNCT03066011
- A Study to Assess the Anti-fatigability Effect of CK-2127107 in Elderly Male and Female Subjects With Limitations in MobilityTerminatedNCT03065959Phase 1
- Treatment Patterns and Key Healthcare Resource Use in Acute Myeloid Leukemia (AML) With or Without FMS-like Tyrosine Kinase-3 (FLT3) Mutation Study Based on Retrospective Chart ReviewCompletedNCT03047083
- A Study for Subjects Who Are Participating in an Astellas-sponsored ASP8273 StudyWithdrawnNCT03042013Phase 2
- A Study of Intermittent Oral Dosing of ASP1517 in Non-Dialysis Chronic Kidney Disease Patients With AnemiaCompletedNCT02988973Phase 3
- A Phase 1 Study of Roxadustat in Subjects With Different Degrees of Renal FunctionCompletedNCT02965040Phase 1
- A Study of Intermittent Oral Dosing of ASP1517 in ESA-untreated Chronic Kidney Disease Patients With AnemiaCompletedNCT02964936Phase 3
- A Study to Assess the Safety and Efficacy of a Tacrolimus Based Immunosuppressive Regimen in Stable Kidney Transplant Recipients Converted From Cyclosporine Based Immunosuppressive RegimenTerminatedNCT02963103Phase 4
- A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical StudyActive, not recruitingNCT02960022Phase 2
- A Study of Intermittent Oral Dosing of ASP1517 in Hemodialysis Chronic Kidney Disease Patients With AnemiaCompletedNCT02952092Phase 3
- A Drug Interaction Study to Evaluate the Pharmacokinetics of ASP1517 and Lanthanum Carbonate HydrateCompletedNCT02952040Phase 1
- A Follow up Study to Determine the Safety and Tolerability of Sub-retinal Transplantation of Human Embryonic Stem Cell Derived Retinal Pigmented Epithelial (hESC-RPE) Cells in Patients With Stargardt's Macular Dystrophy (SMD)CompletedNCT02941991
- A Study of ASP1941 in Combination With Insulin in Patients With Type 1 Diabetes MellitusCompletedNCT02897219Phase 3
- A Study to Evaluate the Efficacy and Safety of ASP1707 in Postmenopausal Female Patients With Rheumatoid Arthritis Taking MethotrexateCompletedNCT02884635Phase 2
- A Study to Evaluate the Pharmacokinetics of ASP1707 and Methotrexate in Patients With Rheumatoid ArthritisCompletedNCT02867306Phase 1
- A Study to Evaluate Escalating Doses of ASP1235 (AGS62P1) Given as Monotherapy in Subjects With Acute Myeloid Leukemia (AML)TerminatedNCT02864290Phase 1
- Study to Evaluate the Safety and Pharmacokinetics of Single Doses of ASP2151 in Healthy Male Subjects and the Effects of FoodCompletedNCT02852876Phase 1
- A Study to Evaluate Safety, Tolerability and Immune Response in Adults Allergic to Peanut After Receiving Intradermal or Intramuscular Administration of ASP0892 (ARA-LAMP-vax), a Single Multivalent Peanut (Ara h1, h2, h3) Lysosomal Associated Membrane Protein DNA Plasmid VaccineCompletedNCT02851277Phase 1
- Study of Ipragliflozin in Patients With Type 2 Diabetes Mellitus Receiving Insulin TherapyCompletedNCT02847091Phase 4
- A Study of Oral Dosing of ASP0456 in Patients With Chronic ConstipationCompletedNCT02809105Phase 3
- A Food Effect Study to Evaluate the Pharmacokinetics of ASP1517CompletedNCT02805374Phase 1
- Post-marketing Surveillance of Bixalomer in Patients With Pre-dialysis Chronic Kidney DiseaseCompletedNCT02805348
- Study to Evaluate the Safety and Pharmacokinetics of ASP2151 in Healthy Non-elderly and Elderly SubjectsCompletedNCT02796118Phase 1
- A Study to Assess the Efficacy and Safety of Ipragliflozin in Subjects With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on MetforminCompletedNCT02794792Phase 3
- A Study To Assess The Efficacy And Safety Of Bismuth Tripotassium Dicitrate (De-Nol) In Combination With Pantoprazole And Pantoprazole Monotherapy In Treatment Of Subjects With Nonsteroidal Anti-Inflammatory Drugs (NSAID)-Induced GastropathyTerminatedNCT02788123Phase 4
- Efficacy and Safety of Dorner Tablets and Aspirin for Prevention of Arteriosclerosis Progress in Type 2 Diabetes Mellitus PatientsTerminatedNCT02786979Phase 4
- A Study of Intermittent Oral Dosing of ASP1517 in Peritoneal Dialysis Chronic Kidney Disease Patients With AnemiaCompletedNCT02780726Phase 3
- A Study of Intermittent Oral Dosing of ASP1517 in Erythropoieses Stimulating Agent (ESA)-Naive Hemodialysis Chronic Kidney Disease Patients With AnemiaCompletedNCT02780141Phase 3
- A Long Term Study of Intermittent Oral Dosing of ASP1517 in Hemodialysis Chronic Kidney Disease Patients With Anemia Converted From Erythropoieses Stimulating Agent (ESA) TreatmentCompletedNCT02779764Phase 3
- A Drug Interaction Study to Evaluate the Pharmacokinetics of ASP015K and MetforminCompletedNCT02760342Phase 1
- Dose Range-finding Study of ASP1585 in Chronic Kidney Disease Patients on Hemodialysis With HyperphosphatemiaCompletedNCT02753894Phase 2
- A Study to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ASP4345 in Patients With SchizophreniaCompletedNCT02720263Phase 1
- Study to Evaluate the Clinical Efficacy and Safety of Tamsulosin Alone or in Combination With Solifenacin for the Treatment in Men With Lower Urinary Tract Symptoms Including Overactive Bladder SymptomsCompletedNCT02715024Phase 4
- Efficacy and Safety Study of the Switch From Cyclosporin to Tacrolimus in Renal Transplant RecipientsCompletedNCT02706678Phase 4
- A Clinical Assessment Study in X-Linked Myotubular Myopathy (XLMTM) SubjectsCompletedNCT02704273
- A Study to Assess the Safety, Tolerability, and Pharmacokinetics of ASP5094 Following Multiple Intravenous Doses in Subjects With Rheumatoid Arthritis on MethotrexateCompletedNCT02698657Phase 1
- Pharmacokinetic Study of ASP1517 With Kremezin®CompletedNCT02693613Phase 1
- A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ASP6294 Administered Intravenously or Subcutaneously in Healthy Young Male and Female SubjectsCompletedNCT02681861Phase 1
- A Retrospective Study Evaluating the Efficacy and Safety of Micafungin Sodium in the Treatment of Invasive Fungal InfectionsCompletedNCT02678598
- A Study to Investigate the Absorption, Metabolism and Excretion of [14C]ASP8273 in Subjects With Solid TumorsWithdrawnNCT02674555Phase 1
- Long-Term Specified Drug Use-Results Survey for Xtandi CapsuleCompletedNCT02669771
- Reproducibility Study of OABSS and Its Response to TreatmentCompletedNCT02667470Phase 4
- Study to Assess the Safety and Efficacy of Tacrolimus (Prograf Capsule/Injection) and Methotrexate (MTX) Combination Therapy for Prevention of Graft Versus Host Disease (GVHD) in Patients Who Received Peripheral Hematopoietic Stem Cell Transplantation From a Sibling DonorCompletedNCT02660684Phase 4
- Long-term Efficacy and Safety of Gabapentin Enacarbil in Japanese Restless Legs Syndrome PatientsCompletedNCT02658188Phase 3
- Post Marketing Study to Evaluate the Safety and Efficacy of Micafungin Against Fungal Infections Caused by Candida Spp or Aspergillus SppTerminatedNCT02646800Phase 4
- Post Marketing Study to Evaluate the Efficacy and Safety of Micafungin Treatment on Invasive AspergillosisTerminatedNCT02646774Phase 4
- EC905 Pharmacokinetic Profile StudyCompletedNCT02634489Phase 1
- ASP8825 - A Study to Investigate the Food Effect on the Pharmacokinetics of ASP8825CompletedNCT02632331Phase 1
- ASP8825 - Pharmacokinetics Study in Patients With Impaired Renal Function and HaemodialysisCompletedNCT02629224Phase 1
- A Cross-sectional Internet Survey to Estimate Prevalence of Lower Urinary Tract Symptoms (LUTS)CompletedNCT02618421
- Special Drug Use Surveillance of Irribow in Female PatientsCompletedNCT02612649
- A Study to Assess the Analgesic Efficacy of ASP7962 in Patients With Pain Due to Osteoarthritis of the KneeCompletedNCT02611466Phase 2
- A Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Escalating Doses of AGS67E Given as Monotherapy in Subjects With Acute Myeloid Leukemia (AML)TerminatedNCT02610062Phase 1
- Pharmacokinetics Study in Patients With Impaired Renal Function and Subjects With Normal Renal FunctionCompletedNCT02603497Phase 1
- Long-term Treatment Study of CDP870 Self-injection in Patients With Active Rheumatoid Arthritis Who Are Participating in the Long-term Treatment Studies (Study 275-08-002 or Study 275-08-004) of CDP870CompletedNCT02586246Phase 3
- Pharmacokinetics Study in Patients With Impaired Hepatic FunctionCompletedNCT02586194Phase 1
- A Study to Investigate the Effect of Hepatic Impairment on the Pharmacokinetics, Safety and Tolerability of ASP2215CompletedNCT02571816Phase 1
- Specified Drug Use-results Survey of Betanis Tablets for Patients With Coexisting Cardiovascular DiseaseCompletedNCT02570035
- Study to Evaluate Sub-retinal Transplantation of Retinal Pigmented Epithelial Cells in Patients With Dry AMDWithdrawnNCT02563782Phase 2
- Global, Multicentre, Non Interventional Advagraf Conversion Registry in Kidney Transplant PatientsCompletedNCT02555787
- A Study of ASP1585 to Evaluate the Bioequivalence Between ASP1585 Granules and ASP1585 CapsulesCompletedNCT02531204Phase 1
- Bioequivalence Evaluation of a New and Current Tablet of ASP015KCompletedNCT02531191Phase 1
- Pharmacodynamics, Pharmacokinetics, and Safety of ASP1941 in Patients With Type 1 Diabetes MellitusCompletedNCT02529449Phase 2
- A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Mirabegron Oral Suspension in Pediatric Subjects From 3 to Less Than 12 Years of Age With Neurogenic Detrusor Overactivity (NDO) or Overactive Bladder (OAB)CompletedNCT02526979Phase 1
- Single and Multiple Dosing Study in Hemodialysis Patients With Hyperphosphatemia in JapanCompletedNCT02510274Phase 1
- A Single and Multiple Oral Dose Study and a Treatment Schedule-finding Study in Non-elderly, Healthy SubjectsCompletedNCT02500953Phase 1
- A Study of ASP8273 in Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor-Naïve Patients With Non-Small Cell Lung Cancer Harboring EGFR MutationsTerminatedNCT02500927Phase 2
- European Observational Study of Enzalutamide in Metastatic Castration Resistant Prostate Cancer (mCRPC)CompletedNCT02495974
- Specified Drug Use Results Survey of Ipragliflozin Treatment in type2 Diabetes PatientsCompletedNCT02479399
- A Study of ASP4070 to Confirm Safety and Immunological Response in Patients With Pollen AllergyCompletedNCT02469688Phase 1
- Long Term Follow Up of Sub-retinal Transplantation of hESC Derived RPE Cells in Patients With AMDCompletedNCT02463344
- A Study to Compare the Efficacy and Safety of Tacrolimus Capsules and Cyclophosphamide Injection in Treatment of Lupus NephritisCompletedNCT02457221Phase 3
- Study to Investigate the Absorption, Metabolism and Excretion of [14C] ASP2215 in Patients With Advanced Solid TumorsCompletedNCT02456883Phase 1
- A Study to Assess the Efficacy and Safety of ASP1941 in Subjects With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Metformin and SitagliptinCompletedNCT02452632Phase 3
- A Study to Investigate the Effect of Oral Doses of Pilocarpine on Salivary Secretion and Static Pupillometry in Healthy SubjectsCompletedNCT02447315Phase 1
- Long Term Follow Up of Sub-retinal Transplantation of hESC Derived RPE Cells in Stargardt Macular Dystrophy PatientsCompletedNCT02445612
- Study to Evaluate the Pharmacokinetics of Fidaxomicin in Inflammatory Bowel Disease (IBD) Subjects With Clostridium Difficile Infection (CDI)CompletedNCT02437591Phase 4
- A Study to Demonstrate Safety and Efficacy of Advagraf in Patients Undergoing Kidney or Liver Transplantation in IndiaCompletedNCT02432053Phase 4
- A Study to Evaluate Dose Responses of Efficacy and Safety of ASP0456 in Patient With Chronic ConstipationCompletedNCT02425722Phase 2
- First-in-human: Single Ascending Dose, Food Effect, Drug-drug Interaction, Multiple Ascending Dose, Proof of PharmacologyCompletedNCT02420782Phase 1
- Observational Study to Evaluate the Safety and Efficacy of ATG-F on Kidney Transplant RecipientsCompletedNCT02392312
- A Prospective, Observational, Multicenter Study of Patients Following Initiation of a New Course of Treatment for Overactive Bladder (OAB)CompletedNCT02386072
- A Dose Escalation and Expansion Study of ASP4132 to Subjects With Advanced Refractory Tumors and LymphomaCompletedNCT02383368Phase 1
- Observational Cohort Study of Patients With Castration-Resistant Prostate Cancer (CRPC)CompletedNCT02380274
- To Validate an Analytical Method to Measure Concentration of Tacrolimus in Blood Taken From Finger PricksTerminatedNCT02377609